28 related articles for article (PubMed ID: 26851030)
1. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of differentially expressed miRNAs in HepG2 cells under normoxic and hypoxic conditions.
Kong F; Ran W; Jiang N; Li S; Zhang D; Sun D
RSC Adv; 2019 May; 9(29):16884-16891. PubMed ID: 35516357
[TBL] [Abstract][Full Text] [Related]
3. The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression.
Samec M; Liskova A; Kubatka P; Uramova S; Zubor P; Samuel SM; Zulli A; Pec M; Bielik T; Biringer K; Kudela E; Benacka J; Adamek M; Rodrigo L; Ciccocioppo R; Kwon TK; Baranenko D; Kruzliak P; Büsselberg D
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1665-1679. PubMed ID: 31127362
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
Winther M; Alsner J; Tramm T; Nordsmark M
Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
[TBL] [Abstract][Full Text] [Related]
7. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
8. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Sachlova M; Svoboda M; Slaby O
Tumour Biol; 2016 Jun; 37(6):8007-18. PubMed ID: 26711784
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of differentially expressed miRNAs in esophageal cancer.
Hu Y; Correa AM; Hoque A; Guan B; Ye F; Huang J; Swisher SG; Wu TT; Ajani JA; Xu XC
Int J Cancer; 2011 Jan; 128(1):132-43. PubMed ID: 20309880
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer.
Winther M; Alsner J; Sørensen BS; Wittrup CF; Tramm T; Baeksgaard L; Hofland K; Holtved E; Nordsmark M
Anticancer Res; 2016 Feb; 36(2):721-30. PubMed ID: 26851030
[TBL] [Abstract][Full Text] [Related]
11. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
12. [Role of miRNA in the diagnosis, prognosis and treatment of esophageal cancer].
Cao XF; Li SQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):161-4. PubMed ID: 21575511
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]